ORIC Pharamceuticals (ORIC) PT Lowered to $37 at JPMorgan
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Price: $13.24 --0%
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 22
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 22
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on ORIC Pharamceuticals (NASDAQ: ORIC) to $37.00 (from $38.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kymera Therapeutics (KYMR) PT Raised to $170 at Guggenheim
- UBS Upgrades PEXA Group Ltd (PXA:AU) to Buy
- UiPath Inc. (PATH) PT Raised to $19 at UBS as Checks Indicate Demand Backdrop Stable
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
